Infectious Diseases 1201 - Infectious Disease Alert - Jan 01, 2008

Target Audience:

This activity is intended for the infectious disease specialist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Stan Deresinski, MD, FACP
Clinical Professor of Medicine
Stanford
Associate Chief of Infectious Diseases
Santa Clara Valley Medical Center

Board Member and Peer Reviewer
Connie Price, MD
Assistant Professor
University of Colorado School of Medicine

Board Member and Updates Author
Carol A. Kemper, MD, FACP
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center
Section Editor, Updates
Section Editors, HIV

Associate Editors
Dean L. Winslow, MD, FACP, FIDSA
Chief, Division of AIDS Medicine
Santa Clara Valley Medical Center
Clinical Professor of Medicine
Stanford University School of Medicine
Section Editor, HIV

Jessica C. Song, MA, PharmD
Assistant Professor
Pharmacy Practice
University of the Pacific
Stockton, CA
Pharmacy Clerkship and Coordinator
Santa Clara Valley Medical Center
Section Editor, Managed Care

Authors
Catherine J. Hill, PharmD Candidate
University of the Pacific

Crystal T. Kimura, PharmD Candidate
University of the Pacific

Lian Chang, PharmD Candidate
University of the Pacific

Subjects:

  • Respiratory Viruses: A View of Future Pandemics
  • Antiretroviral Agents and Lipid Profiles of HIV-Positive Patients: Part 2
  • Updates

Objectives:

  • discuss the diagnosis and treatment of infectious diseases
  • present current data regarding the use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • present the latest information regarding the pros, cons, and cost-effectiveness of new and traditional diagnostic tests
  • discuss new information regarding how infectious diseases (eg, AIDS) are transmitted and how such information can lead to the development of new therapy

Financial Disclosure:

Infectious Disease Alert's Physician Editor, Stan Deresinski, MD, FACP, serves on the speaker's bureau of Merck, Pharmacia, GlaxoSmithKline, Pfizer, Bayer, and Wyeth, and does research for Merck.

Peer Reviewer Connie Price, MD, reports no consultant, stockholder, speaker's bureau, research, or other financial relationship with any company related to this field of study.

Updates author Carol A. Kemper, MD, FACP report no financial relationships relevant to this field of study.

Associate Editor Dean L. Winslow, MD, serves as a consultant for Siemens Diagnostics, and is on the speaker's bureau for Boehringer-Ingelheim and GSK.

Associate Editor Jessica C. Song, MA, PharmD, Catherine J. Hill PharmD Candidate, Crystal T. Kimura, PharmD Candidate, and Lian Change, PharmD Candidate, report no financial relationships relevant to this field of study.

Copyright 2008 AHC Media. All rights reserved.